A medical study presented at the American Society for Radiation Oncology conference suggests a potential breakthrough in treating small cell lung cancer, a relatively rare and aggressive form of the disease. The research indicates that patients with small cell lung cancer that has metastasized to the brain may benefit from a precise radiation technique. Patients receiving this targeted radiation therapy experienced an average survival rate of 17 months. This is a notable improvement compared to the nine months observed in patients who received standard treatment. The study offers hope for improved outcomes for individuals battling this challenging cancer, and was reported on by Hespress - هسبريس جريدة إلكترونية مغربية. Further research is needed to confirm these findings and optimize the treatment protocol.